Express News | Bristol-Myers Squibb's three innovative drugs have been included in the 2024 National Medical Insurance Catalog.

BreakingsNov 28 12:46

Trump Taps Jay Bhattacharya to Lead National Institutes of Health

Seeking AlphaNov 27 19:23

Bristol Myers Squibb to Participate in Citi's 2024 Global Healthcare Conference

BusinesswireNov 26 19:59

Bristol-Myers Squibb Hits 14-month High

Trading EconomicsNov 25 23:45

Merck Phase 3 Study of Winrevair in PAH Meets Primary Endpoint

Seeking AlphaNov 25 23:27

Bernstein Adjusts Price Target on Bristol-Myers Squibb to $62 From $56, Keeps Market Perform Rating

MT NewswiresNov 25 19:06 · Ratings